Director Bethany Mayer filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 16 shares of Lam Research Corp common stock on NASDAQ, with an aggregate market value of $3,336.00.
Eric James Witczak, an officer of Nicolet Bankshares Inc, filed a Form 144 notice on November 6, 2026, proposing to sell 600 shares of the company's common stock through Charles Schwab & Co.
FMR LLC and Abigail P. Johnson filed an amended beneficial ownership statement with the SEC on November 5, 2026, disclosing their combined holdings in Oxford Industries Inc. common stock as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 3,510,708.02 shares of Byrna Technologies Inc. common stock as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed an amended beneficial ownership statement with the SEC on November 5, 2026, disclosing aggregate holdings of 68,966,497.27 shares of Corteva Inc. common stock, representing 10.3% of the class as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 6 to their Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Avalo Therapeutics Inc. as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 8 to their Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Penguin Solutions Inc. as of an October 30, 2026 triggering event.
FMR LLC and Abigail P. Johnson filed an amended Schedule 13G with the SEC on November 5, 2026, disclosing their beneficial ownership position in Natera Inc. common stock as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 3 to a Schedule 13G with the SEC on November 5, 2026, disclosing their beneficial ownership of Class A Common Stock in Braze Inc. as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed an amended Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of approximately 10.4% of the common stock of Lovesac as of an October 30, 2026 triggering event.